Comparison · NCT01576783-e0906817
Docosahexaenoic Acid + Arachidonic Acid vs Placebo: Other Long-term Outcomes: Number of Participants With Developmental Delay
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Docosahexaenoic Acid + Arachidonic Acid vs Placebo: Other Long-term Outcomes: Number of Participants With Developmental Delay. Trial comparisons, record NCT01576783-e0906817. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01576783-e0906817
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.226 | 0.163 | 0.304 | wilson | |
| Risk in group 2 | 0.155 | 0.1 | 0.232 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0704 | -0.0288 | 0.166 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.45 | 0.857 | 2.47 | log | |
| Odds ratio, group 1 over group 2 | 1.59 | 0.831 | 3.03 | log | |
| Number needed to treat, for one more participant with the outcome on Docosahexaenoic Acid + Arachidonic Acid than on Placebo | 14.2 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Docosahexaenoic Acid + Arachidonic Acid | Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)~Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months | 30 | 133 | OG000 |
| Group 2 | Placebo | Corn oil supplement~Placebo: 400 mg corn oil per day for 6 months | 18 | 116 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- OTHER_PRE_SPECIFIED
- Title
- Other Long-term Outcomes: Number of Participants With Developmental Delay
- Description
- Long-term (26-32 months of age) outcomes. This will be evaluated using caregiver reports/diagnoses of developmental delay.
- Time frame
- Long-term effect (approximately 8 months) after intervention completion
- Population
Source ClinicalTrials.gov
Trial
- Title
- Omega Tots: A Randomized, Controlled Trial of Long-chain Polyunsaturated Fatty Acid Supplementation of Toddler Diets and Developmental Outcomes
- NCT number
- NCT01576783
- Phases
- PHASE4
- Conditions
- Preterm Birth, Child Development
- Interventions
- Docosahexaenoic Acid + Arachidonic Acid (DHA+AA), Placebo
- Lead sponsor
- Sarah Keim
- Results first posted
- 2019-05-24
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01576783?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01576783-e0906817